Cargando…

Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?

There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal...

Descripción completa

Detalles Bibliográficos
Autores principales: Culyer, Anthony, Chalkidou, Kalipso, Teerawattananon, Yot, Santatiwongchai, Benjarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961761/
https://www.ncbi.nlm.nih.gov/pubmed/29904588
http://dx.doi.org/10.12688/f1000research.13284.1
_version_ 1783324774554927104
author Culyer, Anthony
Chalkidou, Kalipso
Teerawattananon, Yot
Santatiwongchai, Benjarin
author_facet Culyer, Anthony
Chalkidou, Kalipso
Teerawattananon, Yot
Santatiwongchai, Benjarin
author_sort Culyer, Anthony
collection PubMed
description There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal perspective is “societal”. In this paper we endorse the first principle but dissent from the second. A review of recommended perspectives is presented. The societal perspective is frequently not the one recommended. The societal perspective is shown to be less comprehensive than is commonly supposed, is inappropriate in many contexts and, in any case, is in general not a perspective to be determined independently of the context of a decision problem. Moreover, the selection of a perspective, societal or otherwise, is not the prerogative of analysts.
format Online
Article
Text
id pubmed-5961761
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-59617612018-06-13 Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays? Culyer, Anthony Chalkidou, Kalipso Teerawattananon, Yot Santatiwongchai, Benjarin F1000Res Opinion Article There seems to be a general agreement amongst practitioners of economic evaluations, including Health Technology Assessment, that the explicit statement of a perspective is a necessary element in designing and reporting research. Moreover, there seems also to be a general presumption that the ideal perspective is “societal”. In this paper we endorse the first principle but dissent from the second. A review of recommended perspectives is presented. The societal perspective is frequently not the one recommended. The societal perspective is shown to be less comprehensive than is commonly supposed, is inappropriate in many contexts and, in any case, is in general not a perspective to be determined independently of the context of a decision problem. Moreover, the selection of a perspective, societal or otherwise, is not the prerogative of analysts. F1000 Research Limited 2018-01-17 /pmc/articles/PMC5961761/ /pubmed/29904588 http://dx.doi.org/10.12688/f1000research.13284.1 Text en Copyright: © 2018 Culyer A et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion Article
Culyer, Anthony
Chalkidou, Kalipso
Teerawattananon, Yot
Santatiwongchai, Benjarin
Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
title Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
title_full Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
title_fullStr Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
title_full_unstemmed Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
title_short Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?
title_sort rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. who decides? who pays?
topic Opinion Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961761/
https://www.ncbi.nlm.nih.gov/pubmed/29904588
http://dx.doi.org/10.12688/f1000research.13284.1
work_keys_str_mv AT culyeranthony rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays
AT chalkidoukalipso rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays
AT teerawattananonyot rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays
AT santatiwongchaibenjarin rivalperspectivesinhealthtechnologyassessmentandothereconomicevaluationsforinvestinginglobalandnationalhealthwhodecideswhopays